Bing Huang

Prof. Dr. Bing Huang

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2017 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
HJHan Ju
Han Ju
JZJian Zhang
Jian Zhang
BHBoshi Huang
Boshi Huang
DKDongwei Kang
Dongwei Kang
BHBing Huang
Bing Huang
Peng ZhanPeng Zhan
Peng Zhan

2 July 2018 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JZJian Zhang
Jian Zhang
VPVasanthanathan Poongavanam
Vasanthanathan Poongavanam
DKDongwei Kang
Dongwei Kang
CBChiara Bertagnin
Chiara Bertagnin
HLHuamei Lu
Huamei Lu
XLXinyong Liu
Xinyong Liu

19 November 2021 in Acta Pharmaceutica Sinica B
Verified
Journal Article
Open access
LHLingxin Hou
Lingxin Hou
YZYing Zhang
Ying Zhang
HJHan Ju
Han Ju
SCSrinivasulu Cherukupalli
Srinivasulu Cherukupalli
RJRuifang Jia
Ruifang Jia
Peng ZhanPeng Zhan
Peng Zhan
Influenza is an acute respiratory infectious disease caused by the influenza virus, affecting people globally and causing significant social and economic losses. Due to the inevitable limitations of vaccines and approved drugs, there is an urgent need to discover new anti-influenza drugs with different mechanisms. The viral ribonucleoprotein complex (vRNP) plays an essential role in the life cycle of influenza viruses, representing an attractive target for drug design. In recent years, the functional area of constituent proteins in vRNP are widely used as targets for drug discovery, especially the PA endonuclease active site, the RNA-binding site of PB1, the cap-binding site of PB2 and the nuclear export signal of NP protein. Encouragingly, the PA inhibitor baloxavir has been marketed in Japan and the United States, and several drug candidates have also entered clinical trials, such as favipiravir. This article reviews the compositions and functions of the influenza virus vRNP and the research progress on vRNP inhibitors, and discusses the representative drug discovery and optimization strategies pursued.

1 September 2019 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
RJRuifang Jia
Ruifang Jia
JZJian Zhang
Jian Zhang
WAWei Ai
Wei Ai
XDXiao Ding
Xiao Ding
SDSamuel Desta
Samuel Desta
XLXinyong Liu
Xinyong Liu

4 January 2015 in Virus Genes
Verified
Journal Article
Open access
PDF file
ALAi-Ling Liu
Ai-Ling Liu
YLYuFeng Li
YuFeng Li
Wenbao QiWenbao Qi
Wenbao Qi
XMXiu-Li Ma
Xiu-Li Ma
KYKe-xiang Yu
Ke-xiang Yu
MSMin-Xun Song
Min-Xun Song
H5N1 and H9N2 viruses are important causes of avian influenza in China. H5N1 is typically associated with severe to fatal disease in poultry, while H9N2 is usually associated with mild disease. Differences in viral virulence prompted us to investigate whether innate immune responses would be differentially regulated following infection by H5N1 and H9N2 viruses. To address this hypothesis, expression of a panel of innate immune-related genes including IFN-α, IFN-β, Mx1, OASL, ISG12, IFIT5, IRF7, USP18, SST, and KHSRP in immortal DF-1 cells following H5N1 and H9N2 infection was analyzed and compared by real-time quantitative RT-PCR. Cells infected by either virus overall exhibited a similar expression profile for four ISGs (Mx1, OASL, ISG12, and IFIT5), IFN-α, IFN-β, and SST gene. However, two immune-regulatory genes (IRF7 and KHSRP) were not responsive to highly pathogenic H5N1 infection but were strongly up-regulated in DF-1 cells infected with low pathogenic H9N2 infection. The subtype-dependent host response observed in this study offers new insights into the potential roles of IRF7 and KHSRP in control and modulation of the replication and virulence of different subtypes or strains of avian influenza A virus.

1 February 2021 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
RJRuifang Jia
Ruifang Jia
JZJian Zhang
Jian Zhang
Chiara BertagninChiara Bertagnin
Chiara Bertagnin
SCSrinivasulu Cherukupalli
Srinivasulu Cherukupalli
WAWei Ai
Wei Ai
XLXinyong Liu
Xinyong Liu